WilmerHale Settles Two Patent Infringement Suits for Palomar Against Candela and Syneron

WilmerHale Settles Two Patent Infringement Suits for Palomar Against Candela and Syneron

News

On September 16, WilmerHale client Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for aesthetic treatments, and Syneron Medical Ltd., the leading global aesthetic device company, entered into a comprehensive settlement agreement ending the patent disputes between the companies in which WilmerHale had been representing Palomar and its co-plaintiff, The General Hospital Corporation, which operates Massachusetts General Hospital (MGH). The comprehensive settlement agreement includes two Non-Exclusive Patent License Agreements by Palomar with Candela Corporation (acquired by Syneron in January 2010) and Syneron.

Under the first agreement, Candela and Syneron agreed to pay Palomar $31 million in exchange for a non-exclusive, worldwide, fully paid-up, irrevocable license to US Patent Nos. 5,735,844 and 5,595,568 and foreign counterparts for their professional laser- and lamp-based hair removal systems. In addition, Palomar will receive a royalty-free license to certain Candela patents.

Under the second agreement, Palomar will grant to Syneron and affiliates a non-exclusive, royalty-bearing license in the United States to US Patent Nos. 5,735,844 and 5,595,568 for consumer home-use, lamp-based hair removal products. In addition, Palomar will receive a royalty-free license to certain Syneron and Candela patents. Full details are available here.

This settlement is just one in a series of victories we have obtained for Palomar. Since 1999, WilmerHale has represented Palomar and MGH in a number of disputes involving these patents. This representation has led to more than $125 million in licensing revenue for Palomar and MGH.

WilmerHale Partner Wayne Stoner was lead counsel on all matters for Palomar. His team included Partner Vinita Ferrera; Counsel Kate Saxton and Chris Noyes; Senior Associates Dimple Chaudhary and Sarah Petty; and Associate Leslie Stierman.